Two and a half years ahead of the European Commission, the ETUI with the EBN has unveiled a list of 121 hazardous medicinal products (HMPs) commonly used in the healthcare sector that can cause cancer or reproductive disorders in professionals who… Read more
ETUI Webinar: Cancer risks in healthcare workers
On 12 October, from 11-12h, CET, the ETUI is hosting a webinar on cancer risks in healthcare workers: identification of Hazardous Medicinal Products (HMPs). In the healthcare sector, 12.7 million workers across the EU are potentially exposed to Hazardous… Read more
ETUI Seminar on workers’ protection and chemicals
Ian Lindsley, Secretary of the EBN, attended the 18th Seminar on workers’ protection and chemicals in Zadar, Croatia from 28-29 June 2022. The seminar was organised by the European Trade Union Institute (ETUI) and is financially supported by the European… Read more
Webinar on updating the ISO 23908 standard on safety mechanisms and the prevention of sharps injuries
22nd June 2022. Summary The webinar, chaired by Ian Lindsley, Secretary of the European Biosafety, was well-attended with over 50 attendees and strong engagement from participants. After welcoming attendees, Mr Lindsley talked through the agenda of the webinar and set… Read more
Agenda for webinar on updating the ISO 23908 standard on safety mechanisms and the prevention of sharps injuries
On 22nd June 2022, the European Biosafety Network, in partnership with the Directorate-General for Health and Food Safety (DG SANTE) and the International Organisation for Standardisation (ISO), will host an online webinar on the prevention of sharps injuries and the… Read more
Online workshops: Guidance document for the safe management of hazardous medicinal products at work
A consortium led by RPA is developing a Guidance document for the safe management of hazardous medicinal products at work (HMPs), under contract to the European Commission’s Directorate-General for Employment, Social Affairs and Inclusion (DG EMPL). The aim of the document… Read more
European Biosafety Network Roundtable on Prevention of Exposure to Hazardous Drugs and Reprotoxins in Belgium and Europe
The Roundtable (25/03/2022), chaired by Gitta Vanpeborgh, Belgian Federal Deputy, was well-attended with strong engagement from participants. Hanne Sanders, Adviser on Wellbeing and Safety at Work to Cabinet of the Deputy Prime Minister and Ministry of the Economy and Labour… Read more
Mental and Psychosocial Health in Healthcare; Preventing Medication Errors and Adverse Events and Disorders in Healthcare Workers
Aims and Objectives Improving the mental and psychosocial health and wellbeing of healthcare workers by understanding the causes and effects and preventing mental and psychosocial health disorders and adverse events , mainly medication errors; and by implementing traceability systems and… Read more
Highlights of the outcome of CMD4 and the new provisions of the Carcinogens, Mutagens and Reprotoxins Directive
Inclusion of reprotoxic substances in the scope of the new Carcinogens, Mutagens and Reprotoxins Directive (CMRD). For 12 of these substances, a binding occupational maximum exposure level limit value will be introduced in Annex III of the Directive. Inclusion of… Read more
Stop Cancer at Work Campaign welcomes progress made in protecting workers from cancer and reproductive problems at work
The Stop Cancer at Work Campaign today welcomes the provisional political agreement by the European Parliament and European Council to include for the first time greater protection and reference to reprotoxic substances and hazardous medicinal products (HMPs) in the fourth… Read more
